Burghes AHM - Search Results

1

Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy.

Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, Lowes L, Alfano L, Berry K, Church K, Kissel JT, Nagendran S, L'Italien J, Sproule DM, Wells C, Cardenas JA, Heitzer MD, Kaspar A, Corcoran S, Braun L, Likhite S, Miranda C, Meyer K, Foust KD, Burghes AHM, Kaspar BK. Mendell JR, et al. Among authors: burghes ahm. N Engl J Med. 2017 Nov 2;377(18):1713-1722. doi: 10.1056/NEJMoa1706198. N Engl J Med. 2017. PMID: 29091557 Free article. Clinical Trial.

2

Identification of a 2 base pair nonsense mutation causing a cryptic splice site in a DMD patient.

Winnard AV, Jia-Hsu Y, Gibbs RA, Mendell JR, Burghes AH. Winnard AV, et al. Hum Mol Genet. 1992 Nov;1(8):645-6. doi: 10.1093/hmg/1.8.645. Hum Mol Genet. 1992. PMID: 1301174 No abstract available.

3

A HindIII/BglII dystrophin gene polymorphism in the African-American population.

Prior TW, Papp AC, Snyder PJ, Burghes AH, Wallace BH. Prior TW, et al. Hum Genet. 1992 Aug;89(6):687-8. doi: 10.1007/BF00221965. Hum Genet. 1992. PMID: 1355070

4

Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers.

Klein CJ, Coovert DD, Bulman DE, Ray PN, Mendell JR, Burghes AH. Klein CJ, et al. Am J Hum Genet. 1992 May;50(5):950-9. Am J Hum Genet. 1992. PMID: 1570844 Free PMC article.

5

Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. CIDD Study Group.

Burrow KL, Coovert DD, Klein CJ, Bulman DE, Kissel JT, Rammohan KW, Burghes AH, Mendell JR. Burrow KL, et al. Neurology. 1991 May;41(5):661-6. doi: 10.1212/wnl.41.5.661. Neurology. 1991. PMID: 1781820 Clinical Trial.

6

Spectrum of small mutations in the dystrophin coding region.

Prior TW, Bartolo C, Pearl DK, Papp AC, Snyder PJ, Sedra MS, Burghes AH, Mendell JR. Prior TW, et al. Am J Hum Genet. 1995 Jul;57(1):22-33. Am J Hum Genet. 1995. PMID: 7611292 Free PMC article.

7

A novel cDNA detects homozygous microdeletions in greater than 50% of type I spinal muscular atrophy patients.

Thompson TG, DiDonato CJ, Simard LR, Ingraham SE, Burghes AH, Crawford TO, Rochette C, Mendell JR, Wasmuth JJ. Thompson TG, et al. Nat Genet. 1995 Jan;9(1):56-62. doi: 10.1038/ng0195-56. Nat Genet. 1995. PMID: 7704025

8

Gene therapy for muscle diseases.

Coovert DD, Burghes AH. Coovert DD, et al. Curr Opin Neurol. 1994 Oct;7(5):463-70. doi: 10.1097/00019052-199410000-00015. Curr Opin Neurol. 1994. PMID: 7804468 Review.

9

Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production.

Winnard AV, Mendell JR, Prior TW, Florence J, Burghes AH. Winnard AV, et al. Am J Hum Genet. 1995 Jan;56(1):158-66. Am J Hum Genet. 1995. PMID: 7825572 Free PMC article.

10

Identification of a missense mutation, single base deletion and a polymorphism in the dystrophin exon 16.

Prior TW, Bartolo C, Papp AC, Snyder PJ, Sedra MS, Burghes AH, Mendell JR. Prior TW, et al. Hum Mol Genet. 1994 Jul;3(7):1173-4. doi: 10.1093/hmg/3.7.1173. Hum Mol Genet. 1994. PMID: 7981690 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

161 results

Search Page